Login
Home / 600535.SS : SHH
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Tasly Pharmaceutical Group Co., Ltd

¥13.97 -$1.29 (-8.45%)
SHH · 15 Sep 2026 07:00 UTC
Previous Close
¥14.01
Day Range
¥13.88¥14.07
Year Range
¥12.9¥16.5
Market Cap
20.87B
AVG Volume
14.54M
Trailing/Forward PE
1.56/13.56
PEG ratio
0.09
Dividend Yield
2.22%
Next Earnings Date
2026-10-26
Primary Exchange
Shanghai Stock ExchangeCN
Revenue (CNY)
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CNY)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CNY)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CNY)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CNY)
-1B-500M0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CNY)
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CNY)
01B2B3B4BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CNY)
02B4B6BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-3-2-1024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
0%1%2%3%4%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (CNY)
00.10.20.30.4Jun 20Jun 21Jun 22May 23May 24Oct 24Dec 24Mar 25Oct 25May 26
Book Value Per Share (CNY)
010020030024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CNY)
05B10B15B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
17.52022.52527.5med 21.94Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
4%6%8%10%12%med 6.07%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
2.22.42.62.83med 2.67Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
10121416med 12.47Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
6810121416med 11.67Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
1.41.61.822.2med 1.79Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Tasly Pharmaceutical Group Co., Ltd
600535.SS
Stockpicker

Video analysis: 600535.SS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.